Atlas Trials

A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)

Clinical trial NCT03506425 · COMPLETED

Trial details

NCT number
NCT03506425
Sponsor
Richard Bedlack, M.D., Ph.D.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ALS
Start date
2018-06-21
Primary completion
2019-03-28
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.